Study Of Relative Bioavailability / Bioequivalence Of Two Formulations Of Desloratadine 0.5 Mg/ml Syrup In Healthy Volunteers For Both Sexes [estudo De Biodisponibilidade Relativa/bioequivalência De Duas Formulações De Desloratadina Xarope De 0,5 Mg/ml Em Voluntaŕios Sadios De Ambos Os Sexos]

[No abstract available]7136771Sole, D., Miniti, A., Jen, L.H., Desloratadine in the treatment of adults and adolescents with allergic rhinitis: Analysis of an observational study (2002) Revista Brasileira de Medicina, 59 (10-11), pp. 730-737Rosario, N., Ferraz, F.A.B., Sole, D., Lerio, V.R., Multicentric, open, prospective study of the efficacy and tolerability of desloratadine syrup on the treatment of persistent allergic rhinitis in children (2005) Revista Brasileira de Medicina, 62 (7), pp. 302-307Camelo, C.I., Rinite alérgica: Indicadores de qualidade de vida (2010) J Bras Pneumol, 36, pp. 124-133Ibiapina, C.C., Rinite alérgica: Aspectos epidemiológicos, diagnósticos e terapêuticos (2008) J Bras Pneumol, 34, pp. 230-240Simons, F.E., H1-Antihistamines: More relevant than ever in the treatment of allergic disorders (2003) J Allergy Clin Immunol, 112, pp. 42-52Agrawal, D.K., Anti-inflammatory properties of desloratadine (2004) Clin Exp Allergy, 34, pp. 1342-1348. , ReviewNunes, I.C., New antihistamines: A critical view (2006) J Pediatr, 82, pp. 173-180Pastorino, C.A., Revisão sobre a eficácia e segurança dos anti-histamínicos de primeira e segunda geração (2010) Rev. Bras. Alerg. Imunopatol., 33, pp. 88-92Coppini, M., Cetirizina: Atualização na prevenção e tratamento dos processos alérgicos na infância. Nossa experiência na rinite alérgica (2003) Revista Brasileira de Medicina (RBM), 9, pp. 10-13Gillard, M., Christophe, B., Wels, B., Peck, M., Massingham, R., Chatelain, P., H1 antagonists: Receptor affinity versus selectivity (2003) Inflamm Res, 52, pp. 49-50Banfield, C., Hunt, T., Reyderman, L., Statkevich, P., Padhi, D., Affrime, M., Lack of clinically relevant interaction between desloratadine and erythromycin (2002) Clinical Pharmacokinetics, 41 (SUPPL. 1), pp. 29-35Banfield, C., Herron, J., Keung, A., Padhi, D., Affrime, M., Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole (2002) Clinical Pharmacokinetics, 41 (SUPPL. 1), pp. 37-44Simons, F.E.R., Desloratadine: Clinical pharmacokinetics of a novel H1-receptor antagonist (2002) Clin Pharmacokinet, 41, pp. 01-44Geha, R., Meltzer, E.O., Desloratadine: A new, nonsedating, oral antihistamine (2001) J Allergy Clin Immunol, 107, pp. 751-762Canonica, G.W., Tarantini, F., Compalati, E., Penagos, M., Efficacy of desloratadine in the treatment of allergic rhinitis: A meta-analysis of randomized, double-blind, controlled trials (2007) Allergy: European Journal of Allergy and Clinical Immunology, 62 (4), pp. 359-366. , DOI 10.1111/j.1398-9995.2006.01277.xBachert, C., Maurer, M., Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: Results of four postmarketing surveillance studies (2010) Clin Drug Investig, 30, pp. 109-122Bachert, C., A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis (2009) Clin Ther, 31, pp. 921-944Ferrer, M., Morais-Almeida, M., Guiziva, M., Khanferyan, R., Evaluation of treatment satisfaction in children with Allergic disease treated with an antihistamine (2010) Clin Drug Investig, 30, pp. 15-34Genovese, A., Patella, V., De Crescenzo, G., Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells (1977) Clin Exp Allergy, 27, pp. 559-567Nayak, A.S., Schenkel, E., Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis (2001) Allergy: European Journal of Allergy and Clinical Immunology, 56 (11), pp. 1077-1080. , DOI 10.1034/j.1398-9995.2001.00082.xBachert, C., Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis (2001) Allergy: European Journal of Allergy and Clinical Immunology, Supplement, 56 (65), pp. 14-20Ciprandi, G., Cirillo, I., Vizzaccaro, A., Tosca, M.A., Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: A pilot study (2004) Clinical and Experimental Allergy, 34 (6), pp. 958-964. , DOI 10.1111/j.1365-2222.2004.01960.xMullol, J., Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival (2006) Clin Exp Allergy, 236, pp. 52-58Cyr, M.M., Hayes, L.M., Crawford, L., Baatjes, A.J., Keith, P.K., Denburg, J.A., The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: A placebo-controlled randomized study (2005) International Archives of Allergy and Immunology, 138 (3), pp. 209-216. , DOI 10.1159/000088721Meltzer, E.O., Jalowayski, A.A., Vogt, K., Iezzoni, D., Harris, A.G., Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: Results of a single-center, placebo-controlled trial (2006) Annals of Allergy, Asthma and Immunology, 96 (2), pp. 363-368Kim, K., Sussman, G., Hebert, J., Lumry, W., Lutsky, B., Gates, D., Desloratadine therapy for symptoms associated with perennial allergic rhinitis (2006) Ann Allergy Asthma Immunol, 96, pp. 460-465Monroe, E., Finn, A., Patel, P., Guerrero, R., Ratner, P., Bernstein, D., Cohen, R.M., Ceuppens, J., Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial (2003) Journal of the American Academy of Dermatology, 48 (4), pp. 535-541. , DOI 10.1067/mjd.2003.143Lachapelle, J.M., Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria (2006) J Eur Acad Dermatol Venereol, 20, pp. 288-292Consolidado de Normas de Bioequivalência, , BRASIL. ANVISA. Agência Nacional de Vigilância Sanitária. Disponível em: . Acesso em: 12 set. 201